CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
155 hedge funds and large institutions have $292M invested in Clovis Oncology, Inc. in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
2% less funds holding
Funds holding: 158 → 155 (-3)
13% less capital invested
Capital invested by funds: $337M → $292M (-$45.2M)
Holders
155
Holding in Top 10
1
Calls
$9.32M
Puts
$10.1M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$10.6M | |
| 3 | +$3.03M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.89M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.44M |
Top Sellers
| 1 | -$7.67M | |
| 2 | -$2.44M | |
| 3 | -$1.92M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.58M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$1.5M |